The only analyst I see that covers Teva & has public contact info is Louise Chen of Collins Stewart. So I very politely, with advance thanks, emailed her about it. Y'all will be the first to hear if I hear from her. I'll give her till the end of the week. Then someone else can try her if they like; for now, one of us perstering her about it is probably enough.